Bringing clarity to the complexities of the Huntington disease protein

Dr. Rachel Harding completed her undergraduate and DPhil in structural biology at the University of Oxford, before moving to the University of Toronto for her postdoctoral training. Dr. Harding was awarded the Huntington’s Disease Society of America Berman Topper Career Development fellowship prior to beginning her independent position in October 2022 and is presently a Principal Investigator at the Structural Genomics Consortium (SGC) in Toronto. The focus of Dr. Harding’s research is the huntingtin protein, mutated in people with Huntington’s disease, a devastating, incurable, genetic, neurodegenerative disorder with no disease-modifying treatments available. Dr. Harding studies the structure-function of the huntingtin protein to better understand the mechanisms of disease and find new avenues of therapeutic intervention.